Janos Laszlo Tanyi, MD, PhD
Assistant Professor
University of Pennsylvania
Division of Gynecologic Oncology
3400 Civic Center Blvd.
Third Floor West
Philadelphia,
PA
USA
19104
Biographical Sketch: I am the PI of 3 immunotherapy trial at UPENN. Presented abstract in the past: Kandalaft LE, and Tanyi JL et al.: Autologous Whole-Tumor Antigen Combinatorial Immuno-therapy for Recurrent Ovarian Cancer-Journal of Immunotherapy. 2010, 33 (8): 878-879. Abstracts for the 25th Annual Scientific Meeting of the International Society for Biological Therapy of Cancer, Washington, D.C. (October 1st-4th, 2010)."
Papers:
73 - Focused Plenary
Combination immunotherapy enhances survival in patients with recurrent ovarian cancer
208 - Poster Session A
Preoperative predictors which impact the survival and outcome of secondary cytoreduction in ovarian cancer
244 - Poster Session A
Prognostic factors for overall survival in recurrent ovarian, Fallopian tube, and peritoneal cancer patients treated with bevacizumab: a multisite study
445 - Poster Session B
T cells prepared for adoptive transfer therapy have enhanced homing ability to ovarian cancer microenvironment
451 - Poster Session B
Adoptive transfer of CD3/CD28 co-stimulated T cells improves clinical outcome in patient with recurrent ovarian cancer